Amunix Operating Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Amunix Operating Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10832
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Amunix Operating Inc (Amunix) is a biotechnology company that discovers and develops long-acting protein-based therapeutics. The company develops protein and peptide therapeutics. It uses its proprietary technology platform XTEN, a proprietary recombinant polypeptide that consists of naturally-occurring hydrophilic amino acids. Amunix’s product pipeline includes VRS-317, NB1001, NB1002, BIVV-1001, BIVV-1002, AMX-268, and others. The company develops technologies based on XTEN, a hydrophilic polymer comprised of natural amino acids that can be attached to therapeutic peptides, proteins and small molecules. It offers products for the treatment of hemophilia, diabetes, short bowel syndrome, NASH, Oncology and lipodystrophy. The company partners with biotechnology and pharmaceutical companies. Amunix is headquartered in Mountain View, California, the US.

Amunix Operating Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amunix Operating Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Versartis Raises US$20 Million In Series D Financing 10
Partnerships 12
Amunix Operating Enters into R&D Agreement with Genentech 12
Roche Extends Agreement with Amunix for XTEN technology 13
Licensing Agreements 14
Celgene Enters into Licensing Agreement with Amunix Operating 14
Biogen Exercises Option for Licensing Agreement with Amunix Operating for Factor IX, XTEN technology 15
Amunix Enters into Licensing Agreement with Naia for GLP-1-XTEN 16
Amunix Enters into Licensing Agreement with Naia for GLP-2-XTEN 17
Biogen Idec Exercises Option For Licensing Agreement With Amunix Operating For XTENylated Factor VIII 18
Amunix Expands Licensing Agreement With Janssen For XTEN Technology 19
Amunix Expands Licensing Agreement With Janssen Biotech For Proprietary XTEN Technology 20
Amunix Exercises Option For Licensing Agreement With Janssen Biotech For XTEN Technology 21
Amunix Operating Inc – Key Competitors 22
Amunix Operating Inc – Key Employees 23
Amunix Operating Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Mar 13, 2017: Distinguished Cancer Physician-Scientist Dr. Herbert Pinedo joins Amunix Scientific Advisory Board 25
Feb 13, 2017: Amunix Appoints Fred Hausheer, MD, FACP, as Chief Medical Officer 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Amunix Operating Inc, Pharmaceuticals & Healthcare, Key Facts 2
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amunix Operating Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amunix Operating Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Versartis Raises US$20 Million In Series D Financing 10
Amunix Operating Enters into R&D Agreement with Genentech 12
Roche Extends Agreement with Amunix for XTEN technology 13
Celgene Enters into Licensing Agreement with Amunix Operating 14
Biogen Exercises Option for Licensing Agreement with Amunix Operating for Factor IX, XTEN technology 15
Amunix Enters into Licensing Agreement with Naia for GLP-1-XTEN 16
Amunix Enters into Licensing Agreement with Naia for GLP-2-XTEN 17
Biogen Idec Exercises Option For Licensing Agreement With Amunix Operating For XTENylated Factor VIII 18
Amunix Expands Licensing Agreement With Janssen For XTEN Technology 19
Amunix Expands Licensing Agreement With Janssen Biotech For Proprietary XTEN Technology 20
Amunix Exercises Option For Licensing Agreement With Janssen Biotech For XTEN Technology 21
Amunix Operating Inc, Key Competitors 22
Amunix Operating Inc, Key Employees 23

List of Figures
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amunix Operating Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Amunix Operating Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amore TV, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Amore TV, Inc. Mergers and Acqu …
  • Pernod Ricard SA:企業概要・SWOT・財務分析
    Summary Canadean's "Pernod Ricard SA : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descrip …
  • Aegerion Pharmaceuticals Inc (AEGR):企業のM&A・提携動向(医療分野)
    Summary Aegerion Pharmaceuticals Inc (Aegerion) is a pharmaceutical company that develops therapies for patients with debilitating often fatal and rare diseases. The company provides therapeutics to treat severe inherited lipid disorders. Its therapeutic focus comprise homozygous familial hyperchole …
  • SunEdison, Inc. (formerly MEMC Electronic Materials, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SunEdison, Inc. (formerly MEMC …
  • Cap Gemini S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cap Gemini S.A. Mergers and Acq …
  • Next plc:企業の戦略・SWOT・財務分析
    SummaryNext plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Det …
  • VentiRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary VentiRx Pharmaceuticals Inc (VentiRx) is a biopharmaceutical company that develops and commercializes drugs for the treatment of respiratory, autoimmune diseases and cancer. The company develops toll like receptor 8 agonist and antagonists for the treatment of cancer, respiratory and autoimm …
  • Vectren Corp (VVC):企業の財務・戦略的SWOT分析
    Vectren Corp (VVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mivisa Envases S.A.U.:企業の戦略・SWOT・財務分析
    SummaryMivisa Envases S.A.U. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Sunrise Berhad:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sunrise Berhad Mergers and Acqu …
  • Mission Pharmacal Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mission Pharmacal Company Merge …
  • Hadera Paper Ltd.:企業の戦略・SWOT・財務情報
    Hadera Paper Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hadera Paper Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Simons Group Ltd:企業の戦略・SWOT・財務情報
    Simons Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Simons Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CITGO Petroleum Corporation:企業概要及び戦略的SWOT分析
    CITGO Petroleum Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Spaulding Clinical Research LLC:企業のM&A・提携動向(医療分野)
    Summary Spaulding Clinical Research LLC (Spaulding Clinical Research) is a clinical research company that offers clinical pharmacology research. The company provide products such as spaulding electrocardiograph and Spaulding webECG. It offers data management services including eCRF design and system …
  • Authentidate Holding Corporation (ADAT):企業の財務及び戦略的SWOT分析
    Summary Authentidate Holding Corporation (Authentidate) is a medical equipment company that offers healthcare information technology solutions. The company provides software and patient monitoring products. Its solutions include telehealth solutions, inscrybe hospital discharge and inscrybe referral …
  • Cresset BioMolecular Discovery Ltd(製薬・医療分野):企業M&A動向
    Summary Cresset BioMolecular Discovery Ltd (Cresset) is a chemistry software company. The company provides computational chemistry software and consulting services, particularly in the area of drug discovery. It designs and discovers the active molecules for life science research through its chemist …
  • Dayang Enterprise Holdings Berhad:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dayang Enterprise Holdings Berh …
  • Spyker N.V. (formerly Spyker Cars N.V.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Spyker N.V. (formerly Spyker Ca …
  • Nimbuzz BV:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nimbuzz BV Mergers and Acquisit …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆